MentionFox
Home › funding signals › Matthias Therapeutics, LLC
Company · SEC filings

Matthias Therapeutics, LLC funding history

Before you sign with, sell to or invest in Matthias Therapeutics, LLC

MentionFox check on Matthias Therapeutics, LLC: only 2 sources on file so far (checked 10 November 2026). Run a full check before you rely on it. mentionfox.com/c/company/matthias-therapeutics-llc

Check Matthias Therapeutics, LLC before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Matthias Therapeutics, LLC?

Matthias Therapeutics, LLC has 2 Form D filings on record, from 2026-01-07 to 2026-06-01. Together its new offerings report $150K sold.

Is this your company?

Funding historyFounders and team

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Matthias Therapeutics, LLC: Raised $50K, Form D filed 2026-06-01
Share on LinkedIn Share on X Download image

Keep reading

More on this company and the records around it.

this company elsewhere on the record

What do you want to do with Matthias Therapeutics, LLC?

Is Matthias Therapeutics, LLC a real, registered company?

Matthias Therapeutics, LLC is a registered filer with the SEC (CIK 2104165) and has filed since 2026-01-07. 2 filings are on record, the latest on 2026-06-01.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Matthias Therapeutics, LLC?

Matthias Therapeutics, LLC's filings name Matthew Redling as its officers, directors or promoters.

How much has Matthias Therapeutics, LLC raised?

Its new offerings report $150K sold across 2 offerings, as its own filings state.

Run the free check on Matthias Therapeutics, LLC →

Based
BASKING RIDGE, NEW JERSEY
Year formed
2023
Industry group
Pharmaceuticals
Filings
2
Raised (new offerings)
$150K

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-06-01New offering
first sale 2026-05-14
$50K$500Kdetails · SEC filing
2026-01-07New offering
first sale 2025-11-24
$100K$500Kdetails · SEC filing

Want the whole picture on Matthias Therapeutics, LLC?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Matthias Therapeutics, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Matthias Therapeutics, LLC covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Matthias Therapeutics, LLC's own filings with the SEC. The people those filings name are on the team page.

Filings & events

Fundraising filings

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Matthias Therapeutics, LLC. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

Cite this page

Permanent URL: https://mentionfox.com/company/matthias-therapeutics-llc
Last updated 2026-11-10
Primary record: SEC filing 1 · SEC filing 2
How much has Matthias Therapeutics, LLC raised? $150K in 2 SEC filings. MentionFox, 2026-11-10. https://mentionfox.com/company/matthias-therapeutics-llc